British Thoracic Society corrects damaging impressionBMJ 2003; 326 doi: https://doi.org/10.1136/bmj.326.7400.1211-c (Published 29 May 2003) Cite this as: BMJ 2003;326:1211
- Edmund Neville, chair, executive committee (firstname.lastname@example.org)
- British Thoracic Society, London WC1N 2 PL
EDITOR—Seaton's personal view, “There's none so blind as the double blind”. Discuss, is customarily amusing and challenging.1 It is regrettable, therefore, that his references to the British Thoracic Society and pharmaceutical industry “sponsorship” of its guidelines are incorrect and present a picture that is both misleading and damaging.
The society does not receive funding for the preparation of its guidelines, accepting funding only for printing and distribution costs.
BTS policy on guidelines
Chairmen of guidelines committees should not have shares in a pharmaceutical company or be retained as a consultant with a company. Before appointment their current and recent (three years) involvement with commercial organisations will be reviewed by the chairman and three other members of the Executive …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial